ASX - By Stock
|
IMM |
Re:
Entitlement Offer
|
|
MHendo
|
40 |
16K |
4 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
40
|
16K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
MHendo
|
743 |
339K |
3 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
743
|
339K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
MHendo
|
2.7K |
1.1M |
9 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
MHendo
|
2.7K |
1.1M |
4 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
MHendo
|
2.7K |
1.1M |
10 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
MHendo
|
2.7K |
1.1M |
19 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
19
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
MHendo
|
2.7K |
1.1M |
16 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
MHendo
|
382 |
194K |
3 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
382
|
194K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
MHendo
|
743 |
339K |
5 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
743
|
339K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Ann: US FDA & IRB approves start of ph2b head & neck cancer trial
|
|
MHendo
|
8 |
4.9K |
7 |
06/07/21 |
06/07/21 |
ASX - By Stock
|
8
|
4.9K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Secures Second European Patent For Eftilagimod Alpha, A Soluble Lag-3 Protein, In...
|
|
MHendo
|
86 |
30K |
32 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
86
|
30K
|
32
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Secures Second European Patent For Eftilagimod Alpha, A Soluble Lag-3 Protein, In...
|
|
MHendo
|
86 |
30K |
3 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
86
|
30K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-002 & INSIGHT-004 data to be presented at ASCO
|
|
MHendo
|
260 |
103K |
1 |
21/05/21 |
21/05/21 |
ASX - By Stock
|
260
|
103K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep expands Part B of TACTI-002 collaboration trial
|
|
MHendo
|
35 |
19K |
2 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
35
|
19K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep expands Part B of TACTI-002 collaboration trial
|
|
MHendo
|
35 |
19K |
1 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
35
|
19K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep expands Part B of TACTI-002 collaboration trial
|
|
MHendo
|
35 |
19K |
9 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
35
|
19K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Overall Survival data from ph IIb AIPAC breast cancer trial
|
|
MHendo
|
248 |
114K |
1 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
248
|
114K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
MHendo
|
40 |
19K |
3 |
17/11/20 |
17/11/20 |
ASX - By Stock
|
40
|
19K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Improving results from stage 1 of TACTI-002 ph II trial
|
|
MHendo
|
55 |
24K |
1 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
55
|
24K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Change in substantial holding
|
|
MHendo
|
14 |
7.3K |
0 |
27/07/20 |
27/07/20 |
ASX - By Stock
|
14
|
7.3K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: US patent granted for IMP701 antibody
|
|
MHendo
|
94 |
24K |
7 |
15/07/20 |
15/07/20 |
ASX - By Stock
|
94
|
24K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep AIPAC Ph2b Clinical Results & Update Webcast Slides
|
|
MHendo
|
96 |
49K |
27 |
26/03/20 |
26/03/20 |
ASX - By Stock
|
96
|
49K
|
27
|
|
ASX - By Stock
|
IMM |
Re:
An observation of sorts.....
|
|
MHendo
|
13 |
5.8K |
7 |
11/03/20 |
11/03/20 |
ASX - By Stock
|
13
|
5.8K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Clinical Update & Results Global Webcast Slides
|
|
MHendo
|
88 |
1.5M |
0 |
03/03/20 |
03/03/20 |
ASX - By Stock
|
88
|
1.5M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Clinical Update & Results Global Webcast Slides
|
|
MHendo
|
88 |
1.5M |
4 |
27/02/20 |
27/02/20 |
ASX - By Stock
|
88
|
1.5M
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep reports positive TACTI-002 data
|
|
MHendo
|
129 |
159K |
0 |
22/02/20 |
22/02/20 |
ASX - By Stock
|
129
|
159K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep reports positive TACTI-002 data
|
|
MHendo
|
129 |
159K |
7 |
22/02/20 |
22/02/20 |
ASX - By Stock
|
129
|
159K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
eerily comfortable.....
|
|
MHendo
|
142 |
102K |
0 |
17/02/20 |
17/02/20 |
ASX - By Stock
|
142
|
102K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
eerily comfortable.....
|
|
MHendo
|
142 |
102K |
19 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
142
|
102K
|
19
|
|
ASX - By Stock
|
IMM |
Re:
eerily comfortable.....
|
|
MHendo
|
142 |
102K |
2 |
09/02/20 |
09/02/20 |
ASX - By Stock
|
142
|
102K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
eerily comfortable.....
|
|
MHendo
|
142 |
102K |
2 |
09/02/20 |
09/02/20 |
ASX - By Stock
|
142
|
102K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
eerily comfortable.....
|
|
MHendo
|
142 |
102K |
2 |
09/02/20 |
09/02/20 |
ASX - By Stock
|
142
|
102K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
eerily comfortable.....
|
|
MHendo
|
142 |
102K |
0 |
08/02/20 |
08/02/20 |
ASX - By Stock
|
142
|
102K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Activities Report
|
|
MHendo
|
87 |
68K |
0 |
01/02/20 |
01/02/20 |
ASX - By Stock
|
87
|
68K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Activities Report
|
|
MHendo
|
87 |
68K |
0 |
01/02/20 |
01/02/20 |
ASX - By Stock
|
87
|
68K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
IMM Chart
|
|
MHendo
|
246 |
213K |
0 |
14/11/19 |
14/11/19 |
ASX - By Stock
|
246
|
213K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep granted European patent for eftilagimod alpha
|
|
MHendo
|
9 |
6.2K |
14 |
23/05/19 |
23/05/19 |
ASX - By Stock
|
9
|
6.2K
|
14
|
|
ASX - By Stock
|
IMM |
Re:
11.7 cents Aussie equivalent
|
|
MHendo
|
20 |
1.6K |
1 |
31/07/13 |
31/07/13 |
ASX - By Stock
|
20
|
1.6K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
nasdaq action
|
|
MHendo
|
30 |
2.3K |
1 |
29/07/13 |
29/07/13 |
ASX - By Stock
|
30
|
2.3K
|
1
|
|